Security key
G1933S101
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 2,744,278
- Total 13F value
- $5,927,688
- Share change
- +86,110
- SEC-reported price per share
- $2.16
- Number of holders
- 22
- Value change
- +$186,001
- Number of buys
- 7
- Number of sells
- 4
- Shares outstanding
- 40,791,726
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
22
Top holders
10
CASIF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
CASI Pharmaceuticals, Inc. SEC filings
CASI Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G1933S101
Recent filing periods:
Ownership snapshot
Top reported holders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Foresite Capital Manageme...
Disclosed value leader
Foresite Capital Manageme...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 3.3%
Showing 1-6 of 15 holder rows.
Quick read
Foresite Capital Management VI LLC leads the comparable SEC ownership view at 3.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Foresite Capital Management VI LLC's linked filing trail.
Comparable ownership
Top 5
Foresite Capital Management VI LLC
3.3%
Venrock Adviser, LLC
2.4%
Woodline Partners LP
0.24%
Wellington Shields Capital Manage...
0.21%
ADAR1 Capital Management, LLC
0.11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Foresite Capital Management VI LLC |
13F
Company
|
3.3%
|
$3,762,154
1,329,383 shares
|
— | 31 Dec 2024 |
| Venrock Adviser, LLC |
13F
Company
|
2.4%
|
$2,793,943
987,259 shares
|
— | 31 Dec 2024 |
| Woodline Partners LP |
13F
Company
|
0.24%
|
$282,123
99,690 shares
|
— | 31 Dec 2024 |
| Wellington Shields Capital Management, LLC |
13F
Company
|
0.21%
|
$242,913
85,835 shares
|
— | 31 Dec 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.11%
|
$131,086
46,320 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.1%
|
$111,502
39,400 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
2,744,278
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
22
Q1 2025 holders
22
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend